Treatment of patients with relapsed/refractory multiple myeloma with lenalidomide and dexamethasone with or without bortezomib: prospective evaluation of the impact of cytogenetic abnormalities and of previous therapies
Treatment of patients with relapsed/refractory multiple myeloma with lenalidomide and dexamethasone with or without bortezomib: prospective evaluation of the impact of cytogenetic abnormalities and of previous therapies
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Δεν υπάρχει περίληψη
Έτος δημοσίευσης:
2010
Συγγραφείς:
Dimopoulos, MA Kastritis, E Christoulas, D Migkou, M Gavriatopoulou, M Gkotzamanidou, M Iakovaki, M Matsouka, C Mparmparoussi, D Roussou, M others
